Parkinson’s disease research
Exploring new options for Parkinson’s disease
An estimated 7 to 10 million people worldwide have Parkinson’s disease1. Although there have been many advances in the management of the condition, therapies focus on treating the symptoms, whereas Biogen is focused on slowing down or delaying the disease’s progression.
Parkinson’s is a life-changing condition and those affected currently face an uncertain and unpredictable future. Our vision is to discover, develop and deliver life-changing therapies that address unmet medical needs to improve the lives of patients with movement disorders, and their caregivers, around the world.
- Parkinson’s News Today https://parkinsonsnewstoday.com/parkinsons-disease-statistics/ Accessed 10 May 2019
Our Parkinson’s disease clinical trials
A phase 2 clinical trial for people with Parkinson’s disease